Literature DB >> 29098610

Reported Adverse Events with Painkillers: Data Mining of the US Food and Drug Administration Adverse Events Reporting System.

Jae Min1, Vicki Osborne2, Allison Kowalski2, Mattia Prosperi2.   

Abstract

INTRODUCTION: One-third of adults in the USA experience chronic pain and use a variety of painkillers, such as nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and opioids. However, some serious adverse events (AEs), such as cardiovascular incidents, overdose, and death, have been found to be related to painkillers.
METHODS: We used 2015 and 2016 AE reports from the US FDA's Adverse Events Reporting System (FAERS) to conduct exploratory analysis on the demographics of those who reported painkiller-related AEs, examine the AEs most commonly associated with different types of painkillers, and identify potential safety signals. Summary descriptive statistics and proportional reporting ratios (PRRs) were performed.
RESULTS: Out of over 2 million reports submitted to FAERS in 2015 and 2016, a total of 64,354 AE reports were associated with painkillers. Reports of opioid-associated AEs were more likely to be from males or younger patients (mean age 47.6 years). The highest numbers of AEs were reported for NSAID and opioid use, and the most commonly found AEs were related to drug ineffectiveness, administration issues, abuse, and overdose. Death was reported in 20.0% of the reports, and serious adverse reactions, including death, were reported in 67.0%; both adverse outcomes were highest among patients using opioids or combinations of painkillers and were associated with PRRs of 2.12 and 1.87, respectively.
CONCLUSIONS: This study examined the AEs most commonly associated with varying classes of painkillers by mining the FAERS database. Our results and methods are relevant for future secondary analyses of big data and for understanding adverse outcomes related to painkillers.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29098610     DOI: 10.1007/s40264-017-0611-5

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  8 in total

1.  Opioid use disorder research and the Council for the Advancement of Nursing Science priority areas.

Authors:  Patricia Eckardt; Donald Bailey; Holli A DeVon; Cynthia Dougherty; Pamela Ginex; Cheryl A Krause-Parello; Rita H Pickler; Therese S Richmond; Eleanor Rivera; Carol F Roye; Nancy Redeker
Journal:  Nurs Outlook       Date:  2020-04-09       Impact factor: 3.250

2.  Safety of SGLT2 Inhibitors: A Pharmacovigilance Study from 2013 to 2021 Based on FAERS.

Authors:  Xiang Zhou; Xiaofei Ye; Xiaojing Guo; Dongxu Liu; Jinfang Xu; Fangyuan Hu; Yinghong Zhai; Yongqing Gao; Xiao Xu; Ziwei Dong; Jia He
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

3.  Adverse Events Associated With Radium-223 in Metastatic Prostate Cancer: Disproportionality Analysis of FDA Data Reflecting Worldwide Utilization.

Authors:  Minh-Phuong Huynh-Le; Randall C Shults; Michael J Connor; Jona A Hattangadi-Gluth
Journal:  Clin Genitourin Cancer       Date:  2019-12-05       Impact factor: 2.872

4.  Mining reported adverse events induced by potential opioid-drug interactions.

Authors:  Jinzhao Chen; Gaoyu Wu; Andrew Michelson; Zachary Vesoulis; Jennifer Bogner; John D Corrigan; Philip R O Payne; Fuhai Li
Journal:  JAMIA Open       Date:  2020-04-26

5.  Characteristics and trends of spontaneous reporting of therapeutic ineffectiveness in South Korea from 2000 to 2016.

Authors:  Hye-Jun Kim; Han Eol Jeong; Ji-Hwan Bae; Yeon-Hee Baek; Ju-Young Shin
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

6.  Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system.

Authors:  Yinghong Zhai; Xiaofei Ye; Fangyuan Hu; Jinfang Xu; Xiaojing Guo; Yonglong Zhuang; Jia He
Journal:  J Immunother Cancer       Date:  2019-11-06       Impact factor: 13.751

7.  The Better Management of Patients with Osteoarthritis Program: Outcomes after evidence-based education and exercise delivered nationwide in Sweden.

Authors:  Thérése Jönsson; Frida Eek; Andrea Dell'Isola; Leif E Dahlberg; Eva Ekvall Hansson
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

8.  Fatal Events Associated with Adverse Drug Reactions in the Korean National Pharmacovigilance Database.

Authors:  Hyeong-Geun Jo; Kyeoul Jeong; Ji-Young Ryu; Soyun Park; Yun-Seok Choi; Won-Gun Kwack; Yeo-Jin Choi; Eun-Kyoung Chung
Journal:  J Pers Med       Date:  2021-12-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.